Work

Live attenuated varicella vaccine

Year: 1987

Type: article

Abstract: This article reviews the history and development of live attenuated varicella vaccine from its early days in Japan to its widespread use throughout the world. The vaccine has proven extremely safe after immunization of as many as 10 million healthy children and adults in the United States alone. The vaccine is also highly immunogenic and offers close to 100% protection from severe chickenpox and 90% protection from illness. It is expected to have a major impact on the epidemiology of varicella and zoster in countries with high vaccine uptake.

Source: The Journal of Pediatrics

DOI: 10.1016/s0022-3476(87)80314-1

Author: Anne A. Gershon

Institutions: Columbia University Irving Medical Center, Columbia University

Language: English

Topic: Herpesvirus Infections and Treatments

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,570